Articles by Disease (Neurodegenerative Disorders)

Catalytic DNA: A Novel Tool for Gene Suppression

Journal: Current Drug Targets
Volume: 3
Page: 269-279
Author(s): M.J. Cairns, E.G. Saravolac and L.Q. Sun

Catechol-O-Methyltransferase (COMT)-Mediated Methylation Metabolism of Endogenous Bioactive Catechols and Modulation by Endobiotics and Xenobiotics: Importance in Pathophysiology and Pathogenesis

Journal: Current Drug Metabolism
Volume: 3
Page: 321-349
Author(s): Bao Ting Zhu

Molecular Phenotyping of Mouse Mutant Resources by RNA Expression Profiling

Journal: Current Genomics
Volume: 3
Page: 121-129
Author(s): J. Beckers, J. Hoheisel, W. Mewes, M. Vingron and M. Hrabe de Angelis

The Role of local Insulin-like Growth Factor-1 Isoforms in the Pathophysiology of Skeletal Muscle

Journal: Current Genomics
Volume: 3
Page: 149-162
Author(s): A. Musaro and N. Rosenthal

Preface

Journal: Current Medicinal Chemistry
Volume: 9
Page: ii-ii
Author(s): Tsai Jui-Yi

Preface

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1
Page: i-i
Author(s): P. Jeffrey Conn

Modulation of the Basal Ganglia by Metabotropic Glutamate Receptors: Potential for Novel Therapeutics

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1
Page: 239-250
Author(s): Michael J. Marino and P. Jeffrey Conn

Current and Future Therapeutic Strategies to Target Inflammation in Stroke

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 1
Page: 151-166
Author(s): Wandong Zhang and Danica Stanimirovic

Annexins as Neuroprotective Agents in the Central Nervous System

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 2
Page: 87-107
Author(s): Joanna Bandorowicz-Pikula

Inhibitors and Breakers of Advanced Glycation Endproducts (AGEs): A Review

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 2
Page: 135-161
Author(s): S. Rahbar and J.L. Figarola